Arming Mesenchymal Stromal/Stem Cells Against Cancer: Has the Time Come?

Since mesenchymal stromal/stem cells (MSCs) were discovered, researchers have been drawn to study their peculiar biological features, including their immune privileged status and their capacity to selectively migrate into inflammatory areas, including tumors. These properties make MSCs promising cel...

תיאור מלא

שמור ב:
מידע ביבליוגרפי
Main Authors: Giulia Golinelli, Ilenia Mastrolia, Beatrice Aramini, Valentina Masciale, Massimo Pinelli, Lucrezia Pacchioni, Giulia Casari, Massimiliano Dall’Ora, Milena Botelho Pereira Soares, Patrícia Kauanna Fonseca Damasceno, Daniela Nascimento Silva, Massimo Dominici, Giulia Grisendi
פורמט: Artigo
שפה:Inglês
יצא לאור: Frontiers Media S.A. 2020-09-01
סדרה:Frontiers in Pharmacology
נושאים:
mesenchymal stromal/stem cell
cancer
tumor necrosis factor-related apoptosis-inducing ligand
gene therapy
cell therapy
גישה מקוונת:https://www.frontiersin.org/article/10.3389/fphar.2020.529921/full
תגים: הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!

פריטים דומים